Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 27.02B | 28.84B | 35.30B | 33.27B | 24.87B |
Gross Profit | 4.86B | 5.29B | 6.93B | 7.10B | 4.39B |
EBITDA | 514.00M | 485.00M | 2.16B | 2.62B | 749.00M |
Net Income | -844.00M | -1.29B | 648.00M | 1.28B | -232.00M |
Balance Sheet | |||||
Total Assets | 30.10B | 30.06B | 31.90B | 31.13B | 28.57B |
Cash, Cash Equivalents and Short-Term Investments | 4.83B | 6.17B | 6.50B | 7.14B | 7.18B |
Total Debt | 3.48B | 2.26B | 1.96B | 1.76B | 960.00M |
Total Liabilities | 12.44B | 11.48B | 11.92B | 11.51B | 10.42B |
Stockholders Equity | 17.11B | 18.14B | 19.62B | 19.32B | 17.87B |
Cash Flow | |||||
Free Cash Flow | -2.08B | -124.00M | -308.00M | -864.00M | 2.48B |
Operating Cash Flow | -1.34B | 552.00M | 256.00M | -550.00M | 3.78B |
Investing Cash Flow | -645.00M | -643.00M | -565.00M | -315.00M | -1.32B |
Financing Cash Flow | 431.00M | -370.00M | -470.00M | 540.00M | -344.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥19.25B | 10.98 | 1.96% | 27.72% | 70.12% | ||
79 Outperform | ¥14.42B | 15.08 | 1.90% | 2.44% | 163.48% | ||
71 Outperform | ¥14.39B | 4.92 | 3.26% | -6.23% | 405.48% | ||
67 Neutral | ¥18.10B | 16.04 | 1.85% | 8.71% | 96.54% | ||
66 Neutral | £2.65B | 12.66 | 3.41% | 3.25% | 2.42% | -22.46% | |
60 Neutral | ¥15.12B | 16.43 | 1.66% | 29.02% | ― | ||
54 Neutral | ¥13.62B | ― | 5.29% | -1.14% | 68.17% |